SYSTEMIC autoimmune diseases significantly elevate the risk of developing cardiac arrhythmias and conduction disorders in patients. According to a systematic review and meta-analysis presented at EULAR 2026 that evaluated forty comprehensive studies, adults living with chronic systemic autoimmune conditions experience a pooled risk of rhythm disturbances that is significantly higher than that observed in general population controls. The large-scale analysis encompassed data from more than 210,000 affected patients alongside over 800,000 non-autoimmune control subjects, aiming to identify disease-specific cardiovascular risk patterns across diverse rheumatologic diagnoses. Increased cardiovascular morbidity and mortality remain major clinical concerns in this population, necessitating clearer evidence regarding systemic electrical risk across patient subgroups.
Elevated Risk of Cardiac Arrhythmias in Autoimmune Diseases
The overall findings revealed distinct clinical variations across individual diagnostic categories. Systemic sclerosis and rheumatoid arthritis demonstrated the strongest associations with severe cardiac electrical disturbances among affected individuals. In particular, these autoimmune conditions exhibited marked correlations with elevated rates of atrial fibrillation, complex ventricular arrhythmias, and atrioventricular block. Conduction system impairment was consistently observed across the evaluated clinical cohorts, emphasizing that structural and functional electrical disruption represents a substantial burden in routine autoimmune disease management.
Mechanisms Driving Cardiac Arrhythmias in Autoimmune Diseases
Several biological pathways likely account for the observed electrical remodeling and heightened arrhythmogenic susceptibility in these patient populations. Chronic systemic inflammation frequently induces localized myocardial inflammation, leading directly to progressive fibrotic infiltration within the specialized cardiac conduction system. Additionally, autonomic imbalance further exacerbates electrophysiological instability, predisposing patients to both supraventricular and ventricular rhythm disturbances over extended periods.
Clinical Management and Monitoring Strategies
Given the elevated incidence of rhythm and conduction abnormalities, researchers emphasize the clinical necessity of proactive cardiovascular screening. Incorporating routine baseline electrocardiograms and periodic ambulatory Holter monitoring into standard clinical evaluations for individuals with systemic autoimmune diseases may facilitate the early detection and prevention of rhythm disturbances. Prompt identification of occult electrical impairment allows clinicians to refine patient care strategies, ultimately addressing a primary driver of long-term cardiovascular morbidity and mortality in routine rheumatologic practice.
Reference
Theran Leon JS et al. Cardiac Arrhythmias and Conduction Disorders in Autoimmune Diseases: A Systematic Review and Meta-Analysis. Ann Rheum Dis. 2026; DOI: 10.1136/annrheumdis-2026-eular.B.70.
Featured Image: WINDCOLORS on Adobe Stock.
- Author:
